☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Hemophilia A and B
Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B
August 13, 2020
Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors
March 17, 2020
Load more...
Back to Home
